91 studies found for:    Open Studies | "Lacrimal Apparatus Diseases"
Show Display Options
Rank Status Study
21 Not yet recruiting the Effect of HCG Treatment as a Cardiovascular Disease Morbidity Factor in Sjogren Syndrome Patients
Condition: Primary Sjogren Syndrome With Multisystem Involvement
Intervention: Other: Retrospective study
22 Recruiting Clinical Evaluation of Systane® Gel Drops in Dry Eye Subjects
Condition: Dry Eye
Intervention: Other: Polyethylene Glycol, 0.4%, Propylene Glycol, 0.3% eye drops
23 Not yet recruiting The Effect of Eyelid Surgery on Dry Eye - a Prospective Study
Conditions: Dry Eye Syndrome;   Ptosis;   Dermatochalasis
Intervention:
24 Not yet recruiting Cyclosporine A in the TReatment of Interstitial Pneumonitis Associated With Sjogren's Syndrome
Condition: Sjogren's Syndrome
Interventions: Drug: Cyclosporin A;   Drug: Prednisone;   Drug: Placebo;   Drug: Calcium carbonate D
25 Recruiting Aerobic Exercise in Primary Sjögren's Syndrome
Condition: Sjogren's Syndrome
Intervention: Other: aerobic exercise
26 Recruiting Study of ACCS Eye Drops in Treating Dry Eye
Condition: Dry Eye Syndrome
Interventions: Drug: ACCS;   Drug: Refresh Lubricant Eye Drops
27 Recruiting LME636 in the Relief of Persistent Ocular Discomfort in Patients With Severe Dry Eye Disease
Condition: Dry Eye
Interventions: Biological: LME636 ophthalmic solution;   Biological: LME636 Vehicle
28 Recruiting NovaTears® Eye Drops Observational Study NT-002
Condition: Dry Eye Syndromes
Intervention: Device: NovaTears® Eye Drops
29 Recruiting NovaTears® Eye Drops Observational Study NT-003
Condition: Dry Eye Syndromes
Intervention: Device: NovaTears® Eye Drops
30 Recruiting A Phase 2a, Randomized, Placebo Controlled, Study to Evaluate the Safety and Efficacy of AMG 557/MEDI5872 in Primary Sjögren's Syndrome
Condition: Primary Sjögren's Syndrome
Interventions: Biological: AMG 557/MEDI5872;   Other: Placebo
31 Recruiting Phase 2 Study With Cis-UCA Ophthalmic Solutions in Subjects With Dry Eye
Condition: Dry Eye Syndrome
Interventions: Drug: cis-UCA ophthalmic solution 1.0%;   Drug: cis-UCA ophthalmic solution 2.5%;   Drug: Placebo ophthalmic solution
32 Not yet recruiting Point of Care Testing of Inflammatory Markers in Tears
Condition: Dry Eye Syndrome
Interventions: Other: Eye inflammation;   Other: Without eye inflammation
33 Recruiting Ocular Surface Dry Eye Microbiome
Condition: Dry Eyes
Intervention:
34 Recruiting Ocular Surface Microbiome
Condition: Dry Eye Syndromes
Intervention:
35 Recruiting Safety, Pharmacokinetics and Preliminary Efficacy Study of CFZ533 in Patients With Primary Sjögren's Syndrome
Condition: Primary Sjögren's Syndrome
Interventions: Drug: CFZ533 active;   Drug: CFZ533 placebo
36 Not yet recruiting Platelet -Rich Plasma (PRP) Injection for the Treatment of Severe Dry Eye
Conditions: Dry Eye;   Sjogren Syndrome
Interventions: Drug: PRP injection;   Drug: Standard care Hyaluronic acid eye drops
37 Recruiting Randomised Research Comparing Acupuncture, Herbal Treatment and Artificial Tear Eye Drops in Dry Eye
Condition: Dry Eye
Interventions: Procedure: Acupuncture;   Other: Herbal treatment
38 Not yet recruiting Topical Steroid Treatment For Dry Eye
Condition: Dry Eye
Intervention: Drug: Loteprednol Etabonate (FML)
39 Recruiting The Effects of Cyclosporin A in a Low Humidity Environment, on the Ocular Surface
Condition: Dry Eye
Interventions: Drug: Cyclosporin 0.05% emulsion;   Drug: Endura, Refresh artificial tears
40 Recruiting DNase Treatment for Dry Eyes
Condition: Dry Eye
Interventions: Drug: DNase;   Drug: Vehicle

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years